Increased serum fibroblast growth factor 23 predicts mortality in people with HIV/HCV coinfection
Considering whether elevated FGF23 predicts all-cause mortality in patients with HIV/HCV coinfection.
View PublicationConsidering whether elevated FGF23 predicts all-cause mortality in patients with HIV/HCV coinfection.
View PublicationConsidering barriers to use of PrEP and strategies that may facilitate its uptake.
View PublicationConsidering whether COVID-19 measures such as social distancing and isolation led to increases in loneliness and whether these measures may also have led to elevated sexual risk-taking among some GBM.
View PublicationConsidering the impact of the COVID-19 public health measures on loneliness and sexual behaviour of sexual minority men.
View PublicationConsidering the differential impacts of the rapid transition to virtual care during the COVID-19 pandemic on health-care access and delivery for gay, bisexual and queer men (GBQM).
View PublicationConsidering the differential impacts of the rapid transition to virtual care during the COVID-19 pandemic on health-care access and delivery for gay, bisexual and queer men (GBQM), a population that disproportionately experiences sexual and mental health disparities in Canada.
View PublicationConsidering three cases of treatment-emergent resistance to nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs) in patients with suboptimal treatment adherence.
View PublicationConsidering the reasons for self-perceived low risk of HIV among gay, bisexual, and other men who have sex with men.
View PublicationConsidering why respondent driven sampling recruitment was more successful in Montreal compared to other sites in the Engage Study.
View PublicationThe Carrageenan-gel Against Transmission of Cervical Human papillomavirus trial’s final results.
View Publication